Cargando…

GTSE1 promotes the growth of NSCLC by regulating microtubule‐associated proteins through the ERK/MAPK pathway

The role of G2 and S phase‐expressed‐1 (GTSE1), a microtubule‐localized protein, in non‐small‐cell lung cancer (NSCLC) remains unknown. We explored its role in NSCLC growth. GTSE1 was detected in NSCLC tissues and cell lines using quantitative real‐time polymerase chain reaction. The clinical signif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chuanlin, Wen, Meiyan, Xu, Jiali, Gao, Pengning, Liu, Shanling, Liu, Jiayu, Chen, Ying, Zhou, Lan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260487/ https://www.ncbi.nlm.nih.gov/pubmed/37079439 http://dx.doi.org/10.1111/1759-7714.14908

Ejemplares similares

Natural phytochemicals prevent side effects in BRCA-mutated ovarian cancer and PARP inhibitor treatment
por: Wang, Chuanlin, et al.
Publicado: (2022)

GTSE1 tunes microtubule stability for chromosome alignment and segregation by inhibiting the microtubule depolymerase MCAK
por: Bendre, Shweta, et al.
Publicado: (2016)

GTSE1 Is a Microtubule Plus-End Tracking Protein That Regulates EB1-Dependent Cell Migration
por: Scolz, Massimilano, et al.
Publicado: (2012)

The Nutritional Cytokine Leptin Promotes NSCLC by Activating the PI3K/AKT and MAPK/ERK Pathways in NSCLC Cells in a Paracrine Manner
por: Li, Fengzhou, et al.
Publicado: (2019)

GTSE1 regulates spindle microtubule dynamics to control Aurora B kinase and Kif4A chromokinesin on chromosome arms
por: Tipton, Aaron R., et al.
Publicado: (2017)

Histone deacetylase 6 is overexpressed and promotes tumor growth of colon cancer through regulation of the MAPK/ERK signal pathway
por: Zhang, Shi-Lan, et al.
Publicado: (2019)

MAPK-ERK Pathway
por: Park, Jong-In
Publicado: (2023)

HMGB3 promotes the malignant phenotypes and stemness of epithelial ovarian cancer through the MAPK/ERK signaling pathway
por: Ma, Hanlin, et al.
Publicado: (2023)

GTSE1 promotes cell migration and invasion by regulating EMT in hepatocellular carcinoma and is associated with poor prognosis
por: Wu, Xiaojuan, et al.
Publicado: (2017)

Knockdown GTSE1 enhances radiosensitivity in non–small‐cell lung cancer through DNA damage repair pathway
por: Lei, Xiao, et al.
Publicado: (2020)

ERK/MAPK signalling pathway and tumorigenesis
por: Guo, Yan-Jun, et al.
Publicado: (2020)

Silencing GTSE-1 expression inhibits proliferation and invasion of hepatocellular carcinoma cells
por: Guo, Lei, et al.
Publicado: (2016)

GTSE1 is possibly involved in the DNA damage repair and cisplatin resistance in osteosarcoma
por: Xie, Chaofan, et al.
Publicado: (2021)

Tetramethylpyrazine protects against high glucose-induced vascular smooth muscle cell injury through inhibiting the phosphorylation of JNK, p38MAPK, and ERK
por: Liu, Yutao, et al.
Publicado: (2018)

PICALM exerts a role in promoting CRC progression through ERK/MAPK signaling pathway
por: Zhang, Xitao, et al.
Publicado: (2022)

GTSE1 promotes SNAIL1 degradation by facilitating its nuclear export in hepatocellular carcin oma cells
por: Li, Shan-Shan, et al.
Publicado: (2021)

NCOA7 Regulates Growth and Metastasis of Clear Cell Renal Cell Carcinoma via MAPK/ERK Signaling Pathway
por: Guo, Jiayu, et al.
Publicado: (2023)

GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner
por: Lin, Fen, et al.
Publicado: (2019)

Pan-cancer analyses reveal GTSE1 as a biomarker for the immunosuppressive tumor microenvironment
por: Tan, Ke, et al.
Publicado: (2023)

Apatinib inhibits pancreatic cancer growth, migration and invasion through the PI3K/AKT and ERK1/2/MAPK pathways
por: Hu, Yuan, et al.
Publicado: (2021)

IL-22 Confers EGFR-TKI Resistance in NSCLC via the AKT and ERK Signaling Pathways
por: Wang, Xiaomeng, et al.
Publicado: (2019)

NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway
por: Zhao, Jing, et al.
Publicado: (2017)

GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells
por: Subhash, Vinod Vijay, et al.
Publicado: (2015)

Reduced IQGAP2 Promotes Bladder Cancer through Regulation of MAPK/ERK Pathway and Cytokines
por: Song, Fei, et al.
Publicado: (2022)

FBXO22 Promotes Growth and Metastasis and Inhibits Autophagy in Epithelial Ovarian Cancers via the MAPK/ERK Pathway
por: Li, Minle, et al.
Publicado: (2021)

MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma
por: Moon, Hyuk, et al.
Publicado: (2021)

Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells
por: Cui, Jian, et al.
Publicado: (2019)

Inhibition of MAPK/ERK pathway promotes oligodendrocytes generation and recovery of demyelinating diseases
por: Suo, Na, et al.
Publicado: (2019)

LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway
por: Jiang, Tao, et al.
Publicado: (2020)

USP11 promotes growth and metastasis of colorectal cancer via PPP1CA-mediated activation of ERK/MAPK signaling pathway
por: Sun, Hongze, et al.
Publicado: (2019)

Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy
por: Liu, Feifei, et al.
Publicado: (2018)

Periostin mediates epithelial-mesenchymal transition through the MAPK/ERK pathway in hepatoblastoma
por: Chen, Lu, et al.
Publicado: (2019)

High GTSE1 expression promotes cell proliferation, metastasis and cisplatin resistance in ccRCC and is associated with immune infiltrates and poor prognosis
por: Lei, Pu, et al.
Publicado: (2023)

RPS9 promotes the progression of NSCLC via activation Stat3 and Erk signaling pathways
por: Kong, Yiru, et al.
Publicado: (2022)

Nuclear Receptor Coactivator 2 Promotes Human Breast Cancer Cell Growth by Positively Regulating the MAPK/ERK Pathway
por: Cai, Mengjiao, et al.
Publicado: (2019)

HBV precore G1896A mutation promotes growth of hepatocellular carcinoma cells by activating ERK/MAPK pathway
por: Zhao, Baoxin, et al.
Publicado: (2023)

Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer
por: Peng, Wan-xin, et al.
Publicado: (2017)

Corrigendum to: LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway
Publicado: (2021)

CMaf-Inducing Protein Promotes LUAD Proliferation and Metastasis by Activating the MAPK/ERK Pathway
por: Yu, Xiao-Yan, et al.
Publicado: (2022)

IL-17F promotes osteoblastic osteogenesis via the MAPK/ERK1/2 signaling pathway
por: Zhang, Na, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tlo3gcttfb98rnrdkg968c45ae